Alyeska Investment Group, L.P. Gossamer Bio, Inc. Transaction History

Alyeska Investment Group, L.P.

$25.4 Billion
Q2 2025

A detailed history of Alyeska Investment Group, L.P. transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 4,459,087 shares of GOSS stock, worth $10.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,459,087

Previous 4,163,734 7.09%

Holding current value

$10.1 Million

Previous $4.58 Million 19.74%

% of portfolio

0.02%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$0.78 - $1.44 $230,375 - $425,308	295,353 Added 7.09%	4,459,087 $5.48 Million
Q1 2025 May 15, 2025	SELL	$0.85 - $1.53 $3.95 Million - $7.11 Million	-4,644,780 Reduced 52.73%	4,163,734 $4.58 Million
Q4 2024 Feb 14, 2025	BUY	$0.66 - $1.07 $2.01 Million - $3.25 Million	3,041,058 Added 52.73%	8,808,514 $7.93 Million
Q3 2024 Nov 14, 2024	BUY	$0.79 - $1.25 $221,152 - $349,925	279,940 Added 5.1%	5,767,456 $5.71 Million
Q2 2024 Aug 14, 2024	BUY	$0.51 - $1.27 $2.8 Million - $6.97 Million	5,487,516 New	5,487,516 $4.94 Million
Q4 2023 Feb 14, 2024	BUY	$0.48 - $1.08 $1.4 Million - $3.15 Million	2,913,216 New	2,913,216 $2.65 Million
Q2 2022 Aug 15, 2022	SELL	$5.97 - $9.97 $298,500 - $498,500	-50,000 Reduced 30.38%	114,608 $959,000
Q1 2022 May 16, 2022	BUY	$8.44 - $12.49 $375,934 - $556,329	44,542 Added 37.1%	164,608 $1.43 Million
Q3 2021 Nov 15, 2021	SELL	$7.25 - $13.23 $4.71 Million - $8.6 Million	-650,000 Reduced 84.41%	120,066 $1.51 Million
Q2 2021 Aug 16, 2021	BUY	$8.0 - $9.75 $400,000 - $487,500	50,000 Added 6.94%	770,066 $6.25 Million
Q1 2021 May 17, 2021	BUY	$8.63 - $10.94 $1.57 Million - $2 Million	182,426 Added 33.93%	720,066 $6.66 Million
Q4 2020 Feb 16, 2021	SELL	$8.3 - $13.59 $5.28 Million - $8.64 Million	-635,661 Reduced 54.18%	537,640 $5.2 Million
Q3 2020 Nov 16, 2020	SELL	$11.3 - $14.75 $3.63 Million - $4.74 Million	-321,321 Reduced 21.5%	1,173,301 $14.6 Million
Q2 2020 Aug 14, 2020	BUY	$9.52 - $15.98 $9.69 Million - $16.3 Million	1,017,784 Added 213.44%	1,494,622 $19.4 Million
Q1 2020 May 15, 2020	BUY	$8.0 - $15.48 $791,216 - $1.53 Million	98,902 Added 26.17%	476,838 $4.84 Million
Q4 2019 Feb 14, 2020	BUY	$14.82 - $26.79 $5.32 Million - $9.61 Million	358,663 Added 1860.96%	377,936 $5.91 Million
Q3 2019 Nov 14, 2019	SELL	$16.02 - $22.47 $1.32 Million - $1.86 Million	-82,591 Reduced 81.08%	19,273 $323,000
Q2 2019 Aug 14, 2019	SELL	$16.12 - $22.89 $815,978 - $1.16 Million	-50,619 Reduced 33.2%	101,864 $0
Q1 2019 May 15, 2019	BUY	$17.58 - $23.97 $2.68 Million - $3.66 Million	152,483 New	152,483 $0

Others Institutions Holding GOSS

# of Institutions

140

Shares Held

159M

Call Options Held

2.89M

Put Options Held

130K

View Full List

About Gossamer Bio, Inc.

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $213M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

More about GOSS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alyeska Investment Group, L.P. with notifications on news.

Account

Alyeska Investment Group, L.P. Gossamer Bio, Inc. Transaction History